Davita Healthcare Partners Stock Performance
| DVA Stock | USD 166.99 1.48 0.89% |
DaVita HealthCare has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.36, which means possible diversification benefits within a given portfolio. As returns on the market increase, DaVita HealthCare's returns are expected to increase less than the market. However, during the bear market, the loss of holding DaVita HealthCare is expected to be smaller as well. DaVita HealthCare presently shows a risk of 2.07%. Please confirm DaVita HealthCare skewness, day typical price, and the relationship between the downside variance and daily balance of power , to decide if DaVita HealthCare will be following its price patterns.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in DaVita HealthCare Partners are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, DaVita HealthCare may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
Actual Historical Performance (%)
One Day Return 2.15 | Five Day Return 7.6 | Year To Date Return 58.17 | Ten Year Return 125.24 | All Time Return 4 K |
Last Split Factor 2:1 | Last Split Date 2013-09-09 |
1 | Insider Trading | 09/13/2024 |
2 | DaVita Inc. A Good Breakout Stock to Invest In Right Now | 10/03/2024 |
3 | DaVita Inc Trading 3.05 percent Higher on Oct 15 | 10/15/2024 |
4 | Disposition of 162905 shares by Javier Rodriguez of DaVita HealthCare at 134.65 subject to Rule 16b-3 | 10/18/2024 |
5 | DaVita Q3 2024 Earnings Preview | 10/28/2024 |
6 | Decoding DaVita Inc A Strategic SWOT Insight | 10/30/2024 |
7 | A national campaign to lessen polarization pushes states to ditch partisan primaries | 10/31/2024 |
8 | Disposition of 21602 shares by Joel Ackerman of DaVita HealthCare at 163.56 subject to Rule 16b-3 | 11/01/2024 |
9 | Ranked-choice voting measure fails in Colorado | 11/07/2024 |
10 | DaVitas Move It With Purpose Sets Record Participation in Support of Global Health | 11/12/2024 |
11 | Acquisition by Phyllis Yale of 312 shares of DaVita HealthCare subject to Rule 16b-3 | 11/15/2024 |
12 | Earnings call NRx Pharmaceuticals projects profitability by 2025 | 11/19/2024 |
| Begin Period Cash Flow | 339 M |
DaVita |
DaVita HealthCare Relative Risk vs. Return Landscape
If you would invest 15,485 in DaVita HealthCare Partners on August 27, 2024 and sell it today you would earn a total of 1,214 from holding DaVita HealthCare Partners or generate 7.84% return on investment over 90 days. DaVita HealthCare Partners is generating 0.1397% of daily returns assuming volatility of 2.0696% on return distribution over 90 days investment horizon. In other words, 18% of stocks are less volatile than DaVita, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
DaVita HealthCare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DaVita HealthCare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as DaVita HealthCare Partners, and traders can use it to determine the average amount a DaVita HealthCare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0675
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | DVA | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.07 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average DaVita HealthCare is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DaVita HealthCare by adding it to a well-diversified portfolio.
DaVita HealthCare Fundamentals Growth
DaVita Stock prices reflect investors' perceptions of the future prospects and financial health of DaVita HealthCare, and DaVita HealthCare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DaVita Stock performance.
| Return On Equity | 0.45 | ||||
| Return On Asset | 0.0694 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 24.68 B | ||||
| Shares Outstanding | 82.02 M | ||||
| Price To Earning | 11.43 X | ||||
| Price To Book | 35.11 X | ||||
| Price To Sales | 1.07 X | ||||
| Revenue | 12.14 B | ||||
| Gross Profit | 3.4 B | ||||
| EBITDA | 2.35 B | ||||
| Net Income | 691.53 M | ||||
| Cash And Equivalents | 244.09 M | ||||
| Cash Per Share | 3.98 X | ||||
| Total Debt | 11.12 B | ||||
| Debt To Equity | 5.68 % | ||||
| Current Ratio | 1.41 X | ||||
| Book Value Per Share | 4.68 X | ||||
| Cash Flow From Operations | 2.06 B | ||||
| Earnings Per Share | 9.29 X | ||||
| Market Capitalization | 13.58 B | ||||
| Total Asset | 17.62 B | ||||
| Retained Earnings | 598.29 M | ||||
| Working Capital | 495.69 M | ||||
| Current Asset | 544.53 M | ||||
| Current Liabilities | 292.6 M | ||||
About DaVita HealthCare Performance
By analyzing DaVita HealthCare's fundamental ratios, stakeholders can gain valuable insights into DaVita HealthCare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if DaVita HealthCare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DaVita HealthCare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 6.28 | 8.77 | |
| Return On Tangible Assets | 0.07 | 0.07 | |
| Return On Capital Employed | 0.11 | 0.15 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.65 | 0.69 |
Things to note about DaVita HealthCare performance evaluation
Checking the ongoing alerts about DaVita HealthCare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DaVita HealthCare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DaVita HealthCare has a strong financial position based on the latest SEC filings | |
| About 49.0% of the company shares are held by company insiders | |
| Latest headline from investing.com: Earnings call NRx Pharmaceuticals projects profitability by 2025 |
- Analyzing DaVita HealthCare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DaVita HealthCare's stock is overvalued or undervalued compared to its peers.
- Examining DaVita HealthCare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DaVita HealthCare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DaVita HealthCare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DaVita HealthCare's stock. These opinions can provide insight into DaVita HealthCare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for DaVita Stock analysis
When running DaVita HealthCare's price analysis, check to measure DaVita HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DaVita HealthCare is operating at the current time. Most of DaVita HealthCare's value examination focuses on studying past and present price action to predict the probability of DaVita HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DaVita HealthCare's price. Additionally, you may evaluate how the addition of DaVita HealthCare to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |